These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 25451113)

  • 21. Developmental cell death is enhanced in the cerebral cortex of mice lacking the brain vesicular monoamine transporter.
    Stankovski L; Alvarez C; Ouimet T; Vitalis T; El-Hachimi KH; Price D; Deneris E; Gaspar P; Cases O
    J Neurosci; 2007 Feb; 27(6):1315-24. PubMed ID: 17287506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin transporter knockout and repeated social defeat stress: impact on neuronal morphology and plasticity in limbic brain areas.
    Nietzer SL; Bonn M; Jansen F; Heiming RS; Lewejohann L; Sachser N; Asan ES; Lesch KP; Schmitt AG
    Behav Brain Res; 2011 Jun; 220(1):42-54. PubMed ID: 21238500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered reward circuitry in the norepinephrine transporter knockout mouse.
    Gallagher JJ; Zhang X; Hall FS; Uhl GR; Bearer EL; Jacobs RE
    PLoS One; 2013; 8(3):e57597. PubMed ID: 23469209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidepressant-like effect of the ethanolic extract from Suanzaorenhehuan Formula in mice models of depression.
    Liu J; Qiao W; Yang Y; Ren L; Sun Y; Wang S
    J Ethnopharmacol; 2012 May; 141(1):257-64. PubMed ID: 22366432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Norepinephrine transporter heterozygous knockout mice exhibit altered transport and behavior.
    Fentress HM; Klar R; Krueger JJ; Sabb T; Redmon SN; Wallace NM; Shirey-Rice JK; Hahn MK
    Genes Brain Behav; 2013 Nov; 12(8):749-59. PubMed ID: 24102798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mouse strain differences in immobility and sensitivity to fluvoxamine and desipramine in the forced swimming test: analysis of serotonin and noradrenaline transporter binding.
    Sugimoto Y; Kajiwara Y; Hirano K; Yamada S; Tagawa N; Kobayashi Y; Hotta Y; Yamada J
    Eur J Pharmacol; 2008 Sep; 592(1-3):116-22. PubMed ID: 18655786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A ketogenic diet and knockout of the norepinephrine transporter both reduce seizure severity in mice.
    Martillotti J; Weinshenker D; Liles LC; Eagles DA
    Epilepsy Res; 2006 Mar; 68(3):207-11. PubMed ID: 16356685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A role for glucocorticoid-signaling in depression-like behavior of gastrin-releasing peptide receptor knock-out mice.
    Monje FJ; Kim EJ; Cabatic M; Lubec G; Herkner KR; Pollak DD
    Ann Med; 2011 Aug; 43(5):389-402. PubMed ID: 21254899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of norepinephrine transporter inactivation on locomotor activity in mice.
    Mitchell HA; Ahern TH; Liles LC; Javors MA; Weinshenker D
    Biol Psychiatry; 2006 Nov; 60(10):1046-52. PubMed ID: 16893531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Na(+)/Cl(-)-dependent transporter for catecholamines, identified as a norepinephrine transporter, is expressed in the brain of the teleost fish medaka (Oryzias latipes).
    Roubert C; Sagné C; Kapsimali M; Vernier P; Bourrat F; Giros B
    Mol Pharmacol; 2001 Sep; 60(3):462-73. PubMed ID: 11502876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of chronic norepinephrine transporter inactivation on seizure susceptibility in mice.
    Ahern TH; Javors MA; Eagles DA; Martillotti J; Mitchell HA; Liles LC; Weinshenker D
    Neuropsychopharmacology; 2006 Apr; 31(4):730-8. PubMed ID: 16052243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transient developmental expression of monoamine transporters in the rodent forebrain.
    Lebrand C; Cases O; Wehrlé R; Blakely RD; Edwards RH; Gaspar P
    J Comp Neurol; 1998 Nov; 401(4):506-24. PubMed ID: 9826275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deficiency of alpha-calcitonin gene-related peptide induces inflammatory responses and lethality in sepsis.
    Lee JK; Jung JS; Park SH; Sim YB; Suh HW
    Cytokine; 2013 Nov; 64(2):548-54. PubMed ID: 24021706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
    Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
    Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurotrophin and neuropeptide expression in mouse brain is regulated by knockout of the norepinephrine transporter.
    Haenisch B; Gilsbach R; Bönisch H
    J Neural Transm (Vienna); 2008 Jul; 115(7):973-82. PubMed ID: 18335160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-dependent regulation of depression-like behaviors through modulation of adrenergic receptor α₁A subtype expression revealed by the analysis of interleukin-1 receptor antagonist knockout mice.
    Wakabayashi C; Kiyama Y; Kunugi H; Manabe T; Iwakura Y
    Neuroscience; 2011 Sep; 192():475-84. PubMed ID: 21722710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a β-substituted phenylethylamine in mice.
    Dhir A; Malik S; Kessar SV; Singh KN; Kulkarni SK
    Eur Neuropsychopharmacol; 2011 Sep; 21(9):705-14. PubMed ID: 21277753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response of hypothalamic oxytocinergic neurons to immobilization stress is not dependent on the presence of corticotrophin releasing hormone (CRH): a CRH knock-out mouse study.
    Pirnik Z; Petrak J; Bundzikova J; Mravec B; Kvetnansky R; Kiss A
    J Physiol Pharmacol; 2009 Jun; 60(2):77-82. PubMed ID: 19617649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional classification of antidepressants based on antagonism of swim stress-induced fos-like immunoreactivity.
    Duncan GE; Knapp DJ; Johnson KB; Breese GR
    J Pharmacol Exp Ther; 1996 May; 277(2):1076-89. PubMed ID: 8627519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic deletion of the norepinephrine transporter decreases vulnerability to seizures.
    Kaminski RM; Shippenberg TS; Witkin JM; Rocha BA
    Neurosci Lett; 2005 Jul 1-8; 382(1-2):51-5. PubMed ID: 15911120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.